EMHA Calendar
All EMHA Members
EMHA News
Sad news at EMHA
10/04/2019 It is a sad day for the headache world and for the EMHA it is with the greatest sadness that we announce the sudden death of Dr.Paolo Rossi, Board Mem...
New drugs, decades in the making, are providing relief for migraines.
11/12/2018 Nancy Baum Lipsitz remembers the night the pain began. She’d had a glass of white wine with a friend and went to bed with a terrible headache. The n...
YOGA AND MIGRAINE
05/12/2018 What Can Yoga Do for Migraine Relief? Yoga can provide more than just physical fitness. It can bring calm and peace to your mind and body, as well as...
“Green light” to Lilly’s monoclonal antibody to migraine
28/11/2018 Eli Lilly announces that the European Commission (EC) has approved the commercialization of galcanezumab ( Emgality ) as a prophylactic treatment of...
Migraine Atlas by AEMICE
14/11/2018 AEMICE together with Universidad de Sevilla (Seville University) and Novartis and a scientific committee of expert neurologists has created the "Mi...
Congratulations Kalina!!
09/11/2018 We would like to give the warmest and biggest congratulations to our Board Officer and Cluster Headache Delegate, Kalina Tyminski!!! We are beyond pro...
Master of Headache Disorder
26/10/2018 Copenhagen University is now offering a Master on Headache Disorders. It´s a continuing professional development programme for healthcare profession...
Migraine Association of Ireland
19/10/2018 Migraine Awareness Week 2018 MAI held an accredited Health Care Professional Seminar, during which two international speakers presented on Migraine: D...
How to access innovative treatments by FindMeCure Foundation
19/10/2018 FindMeCure Widget Medical science has been rapidly advancing in the recent decades and we can prove that with many examples: new therapies for diabe...
#MoveForMigraine
18/10/2018 #MoveForMigraine Migraine remains an overlooked and misunderstood condition in many parts of Europe, including Belgium. The disease suffers from a lac...
What is EMHA?
The European Migraine & Headache Alliance is a non-profit, patient umbrella group which was launched in 2006. Since then, the Alliance has grown to represent 30 patient groups from across the continent.
The development of European umbrella organisations is a natural progression with more relevance for European nations.
About Headache
Headache disorders are among the most common disorders of the nervous system. These include tension-type headache (TTH), migraine and chronic daily headache syndromes as well as the more rare disorders, cluster headache and trigeminal neuralgia.
EMHA Data charts
Statistical data
In 2010, EHA launched its Madrid Manifesto for Migraine/ Headache Disorders at the Spanish Parliament to mark European Migraine Day of Action. This document outlined our 5-year objectives to improve migraine management, education and awareness across Europe.
Projects
EMHA is the result of the need of making society know the different types of migraine that exist and that currently are not receiving the importance they deserve. EMHA fights for the human rights, that is why is present in activities and events that are relevant for headache issues. Trying to give voice for those ones who need it. EMHA works as well in finding a way to mitigate migraine, by joining forces and strengthening partnerships which are aiming the same objective.
